Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap

Mucormycosis has recently been recognized as a severe complication of COVID-19 with high fatality rates. We report a fatal case of COVID-19 associated mucormycosis (CAM) in a non-diabetic immunocompromised patient, who was first misdiagnosed and treated for COVID-19 associated aspergillosis (CAPA)....

Descripción completa

Detalles Bibliográficos
Autores principales: Crone, Cornelia Geisler, Helweg-Larsen, Jannik, Steensen, Morten, Arendrup, Maiken Cavling, Helleberg, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Masson SAS on behalf of SFMM. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600800/
https://www.ncbi.nlm.nih.gov/pubmed/34826672
http://dx.doi.org/10.1016/j.mycmed.2021.101228